Polymorphisms within the CTLA4 gene are associated with infant atopic dermatitis

G Jones1, S Wu, N Jang

  • 1Institute for Immunology and Allergy Research (Westmead Millennium Institute), University of Sydney, Westmead Hospital, Australia. graham_jones@wmi.usyd.edu.au

Insights

Genetic variations in the CTLA4 gene are linked to early-onset atopic dermatitis (AD) in children. The +49(A)/CT60(A) haplotype appears to be a shared genetic risk factor for both AD and asthma.

Area of Science:

  • Immunogenetics
  • Pediatric Dermatology
  • Allergy Research

Background:

  • Atopic dermatitis (AD) is a prevalent childhood skin disorder with significant physical and psychological impacts.
  • While environmental factors play a role, AD has a strong genetic basis, potentially linked to other allergic conditions like asthma.

Purpose of the Study:

  • To investigate the association between polymorphisms in the cytotoxic T-lymphocyte-associated protein 4 (CTLA4) gene and early-onset childhood atopic dermatitis (AD).
  • CTLA4 is a key regulator of T-cell activity and has been previously linked to asthma and autoimmune diseases.

Main Methods:

  • A family-based cohort of 112 children diagnosed with AD within the first three years of life was studied in Western Sydney, Australia.
  • The transmission disequilibrium test was employed to assess associations of the +49 and CT60 polymorphisms in the CTLA4 gene.

Main Results:

  • The +49(A) allele showed a significant association with AD (P = 0.037).
  • The CT60(A) allele displayed borderline significance (P = 0.055).
  • A significant association was found for the combined +49(A)/CT60(A) haplotype (P = 0.002), indicating a shared genetic risk factor.

Conclusions:

  • Polymorphisms in the CTLA4 gene are associated with early-onset infant atopic dermatitis.
  • The findings suggest that the +49(A)/CT60(A) CTLA4 haplotype is a common genetic risk factor for both atopic dermatitis and asthma.
Abstract

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Epistasis01:39

Epistasis

In addition to multiple alleles at the same locus influencing traits, numerous genes or alleles at different locations may interact and influence phenotypes in a phenomenon called epistasis. For example, rabbit fur can be black or brown depending on whether the animal is homozygous dominant or heterozygous at a TYRP1 locus. However, if the rabbit is also homozygous recessive at a locus on the tyrosinase gene (TYR), it will have an unshaded coat that appears white, regardless of its TYRP1...